# Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Study · id `cardio:ct-nct01848873` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01848873](<https://clinicaltrials.gov/study/NCT01848873>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01848873

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 756 participants.

## Technical summary

Registry record NCT01848873. Randomized; quadruple masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 756 participants (planned count; ClinicalTrials.gov record NCT01848873, source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT01848873, source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)
- Primary completion: 2013-08 (anticipated) (ClinicalTrials.gov record NCT01848873, source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)
- Completion: 2013-08 (anticipated) (ClinicalTrials.gov record NCT01848873, source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01848873, source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01848873-2013-05-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
- Condition: Essential Hypertension
- Intervention (Drug): Amlodipine
- Intervention (Drug): amlodipine-FA tablet, low dose group
- Intervention (Drug): amlodipine-FA tablet ,high dose group
- Lead sponsor: Shenzhen Ausa Pharmed Co.,Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Peking University First Hospital
- Collaborator class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER
- Collaborator: Capital Medical University
- Collaborator class: OTHER
- Collaborator: Fudan University
- Collaborator class: OTHER
- Collaborator: Ruijin Hospital
- Collaborator class: OTHER
- Collaborator: Nanchang University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Fujian Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: China Medical University, China
- Collaborator class: OTHER
- Collaborator: Xi'an Jiaotong University
- Collaborator class: OTHER
- Collaborator: Xuzhou Medical University
- Collaborator class: OTHER
- Collaborator: Anhui Medical University
- Collaborator class: OTHER
- Collaborator: Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Blood pressure and homocysteine-lowering effects of the amlodipine/folic acid combination in patients with hypertension and serum homocysteine concentration ≥10 μmol/l (H-type hypertension): a multicenter, randomized, double-blind, parallel-controlled clinical trial (`cardio:pubmed-42861767`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 12 registry organizations

## Provenance

Content hash: 99a70cf2befe4e8b0e8226a270e02fde0422590cd1d110889725b2f067e73573
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
